Dawex Announces the Launch of the Japan Data Exchange (JDEX) to Foster a New Data Community
30.11.2020 12:00:00 EET | Business Wire | Press release
Dawex, the leading data exchange technology company, today announced with Kanematsu Corporation and Japan Data Exchange Inc. the launch of JDEX, a Data Exchange Platform to create a large data trading community in Japan, spanning across industry, academia, and government, and contribute to the promotion of a cross-industry and cross-border data exchange environment. The platform, relying on Dawex Data Exchange technology and operated by Kanematsu, will serve the multinational trading corporation’s domestic and foreign network. JDEX platform enables the sourcing, exchange, sharing and commercialization of data products leveraging the platform's advanced features and capabilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005371/en/
JDEX Platform - Login screen (Photo: Dawex)
Emerging as a key component of the data economy, Data Exchanges are now clearly top of the agenda of an increasing number of corporations, public institutions and governments around the world. With new initiatives on frameworks and policies multiplying everywhere such as GAIA-X in Europe, Data Trading Alliance in Japan, the World Economic Forum or the Data Exchange Association (DXA), the market is increasingly being regulated and standardized encouraging the development of trusted cross-border, cross-industry data ecosystems such as JDEX.
Awarded “Technology Pioneer” and chosen for the Global Future Council on Data Policy by the World Economic Forum in June 2020, Dawex delivered to Kanematsu the means to deploy a powerful data exchange strategy and to create value as the orchestrator of a rich data ecosystem in Japan and abroad.
“Developing the Japan Data Exchange (JDEX) is a crucial part of Kanematsu’s data strategy that we initiated three years ago. By partnering with Dawex, we rely on the most advanced data exchange technology available today to create and support a new data community. The flexibility and sophistication of Dawex solution enables us to offer a secure and trusted environment to data providers and data acquirers and easily address their business needs.” said Mr. Masahiro Harada, Senior Executive Officer, Electronics and Devices Division at Kanematsu Corporation.
“We are very excited to see this realization with Kanematsu coming to fruition and to observe the multiplication of cross-border and cross-industry data exchange initiatives. This results from a strong commitment impulsed by the Japanese government through its regulations, and initiatives such as the Osaka Track, enabling JDEX to build a rich data community.” stated Laurent Lafaye co-CEO of Dawex.
“Now armed with advanced data infrastructure relying on Dawex technology, and leveraging a mature governance framework, the Japan Data Exchange will unlock the full potential of a growing data ecosystem and set an example for the transition into a data-driven economy.” says Fabrice Tocco, co-CEO of Dawex. “The data marketplace will enable the development of new data models and foster innovation in a trusted and secure environment.”
About Dawex
Dawex, the leading data exchange technology company and the operator of the largest data marketplace, allows organizations to orchestrate data circulation, by sourcing and exchanging data securely, and in full compliance with regulations. Today 12,000+ organizations from 20+ sectors rely on Dawex Global Data Marketplace and Data Exchange Platform solutions to build their data exchange strategy. In 2020, Dawex is named Technology Pioneer by the World Economic Forum. Created in 2015, Dawex is a tech company with offices in France and Canada, expanding business operations to Asia and the Middle East. www.dawex.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201130005371/en/
Contact information
Dawex press contact
Charles Parant
press@dawex.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202630.8.2026 00:54:00 EEST | Press release
Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon company, in strategic partnership with the Emirates Falconers’ Club, at ADNEC Centre Abu Dhabi. The exhibition runs until 6 September. The falcon, owned
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 01:40:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total amount of blood in the body. Maintaining controlled hematocrit levels below 45% is the primary treatment goal in PV.1 “For patients living with PV, uncontrolled hematocrit can have serious consequences, including an elevated risk of life-threatening thrombotic events," said Andrew T. Kuykendall, M.D., VERIFY lead investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “Curre
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release
Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom